Author： Newton-Howes Giles Tyrer Peter
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.10, 2003-10, pp. : 1643-1649
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Although there are many methodological uncertainties in the treatment of personality disorders, which make it difficult to be confident about efficacy, there is growing evidence that at least in some personality disorders, drug treatment may be of value. Borderline personality disorder is a condition in which treatment evidence is the most promising, but it is also one of the most difficult disorders to disentangle the mental state from personality components. In summary, there is reasonable evidence that antidepressants, particularly serotonin re-uptake inhibitors and monoamine oxidase inhibitors, have beneficial effects independent of their antidepressive ones and albeit, less favourable, evidence that antipsychotic drugs and mood stabilisers may also be of value. None of this evidence is yet sufficient to point to any specific drug treatment indications.
Related content
Personality disorders are disorders of the personality?
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :
Access to resources
Recommend
Pharmacotherapy of Pediatric Anxiety Disorders
Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 3, 2014-06 ,pp. :
Pharmacotherapy of Alcohol Use Disorders
By Buonopane Alessandra Petrakis Ismene
Substance Use & Misuse, Vol. 40, Iss. 13-14, 2005-12 ,pp. :